AAREYDRUGS

HealthcareDrug Manufacturers - Specialty & GenericMicro Cap
Aarey Drugs & Pharmaceuticals Limited

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS), operating in the Healthcare sector as a Drug Manufacturer - Specialty & Generic, manufactures and sells active pharmaceutical in...

हिन्दी में

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS), स्वास्थ्य सेवा क्षेत्र के दवा निर्माता - स्पेशलिटी और जेनेरिक उप-क्षेत्र में कार्यरत है। यह भारत में एक्टिव फार्मास्युटिकल इंग्र...

₹104.08+0.18%1D
Previous trading day close · Data updates after market close
1W: +0.0%
1M: +4.1%
6M: +52.6%
1Y: +26.6%
46/100
Below AvgResearch Score
Market Cap
₹262 Cr
Micro Cap
P/E Ratio
60.46
Premium
P/B Ratio
1.74
Reasonable
ROE
3.0%
Weak
ROCE
7.4%
Average
Debt / Equity
0.25
Low debt
Div. Yield
N/A
EV/EBITDA
20.65
Fair
52W Low: ₹50.31Current: ₹104.0852W High: ₹110
At 90% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
49/100
Growth
Revenue, EPS, profit growth
34/100
Valuation
PE, PB, EV/EBITDA vs sector
35/100
Risk
Debt levels, volatility, coverage
71/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
60.46(Premium)
Forward P/E
N/A
P/B Ratio
1.74(Reasonable)
P/S Ratio
0.50(Good)
EV/EBITDA
20.65(Expensive)
Dividend Yield
N/A
5Y CAGR
N/A
Revenue Growth
-1.1%(Moderate)
Profitability
ROE
3.0%(Average)
ROCE
7.4%(Average)
ROA
1.4%(Average)
Net Margin
0.8%(Low)
EBITDA Margin
2.8%
Financial Health
Debt to Equity
0.25(Low debt)
Current Ratio
1.78(Healthy)
Quick Ratio
1.48(Good)
Interest Coverage
2.08x(Low)
Technical Indicators
Based on previous trading day close
RSI (14)
55(Neutral)
RSI Exp (14)
58(Neutral)
MACD
3.672(Bullish)
MACD Signal
3.926
BB Position
67%(Middle)
BB Width
11.89%(Normal)
ADX (14)
18.6(Sideways)
Williams %R
-46.4(Neutral)
MFI (14)
56(Neutral)
CCI (20)
49(Neutral)
Stoch %K
54(Neutral)
ATR (14)
4.46(Avg True Range)
OBV (M)
17.4(Positive)
1W OBV Chg
3.8%(Increasing)
Rel Volume
0.88x(Normal)
Volatility
47.9%(High)
Max DD 1Y
-52.7%(High loss)
EMA 200
83.1
EMA 50
94.8
SMA 200
79.5
vs SMA 50
12.8%(Above SMA50)
vs SMA 200
30.9%(Above SMA200)
Volume
1.52L
Avg Vol 3M
1.7L
Shareholding Pattern
Promoter
37.7%
Low stake
FII
4.2%
DII / MF
1.6%
Share AAREYDRUGS
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.